Home > Specialties > IVD Test Reagent/Kits, Immunoassay, Thyroid Hormone, Thyroglobulin

IVD Test Reagent/Kits, Immunoassay, Thyroid Hormone, Thyroglobulin

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses of a sample of body fluids (typically serum) to determine thyroglobulin (Tg), a large glycoprotein (a prohormone) that is stored in the follicular colloid of the thyroid gland and participates in the synthesis of triiodothyronine (T3) and thyroxin (T4). Increased levels of Tg are associated to thyroid papillary and follicular carcinomas, thyroid adenoma, and other diseases of the thyroid; its determination is particularly useful in monitoring recurrence of thyroid carcinoma following surgical resection. Determining the level of thyroglobulin in serum samples is difficult if antithyroglobulin antibodies are present, as frequently occurs in thyroid cancer patients.

Entry Terms : "Thyroglobulin Determination Reagents" , "Reagents, Thyroglobulin" , "Reagents, Immunoassay, Thyroid Hormone, Thyroglobulin"

UMDC code : 17398

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-9 of 9 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

ALPCO Diagnostics

Company Type: Parent

ALPCO distributed one product in the United States. Within a decade of its founding, ALPCO partnered with more than 40 manufactures and grew its distribution network throughout North America. To further meet the needs of its customers, ALPCO expanded in 2004 with the advent of its Research and Development Division. Within three years, ALPCO launched its first line of organically developed enzyme-linked immunosorbent assay (ELISA) kits for insulin. Since then, ALPCO has solidified its place in the domestic and international markets not only as a distributor, but also as a developer and manufacturer of immunoassays.

Biomerica Inc

Company Type: Parent

Since 1971, Biomerica has developed, manufactured, and distributed medical diagnostic products for the early detection and monitoring of chronic diseases and certain medical conditions.

Biotecx Laboratories Inc

Company Type: Parent

BIOTECX is a Houston Texas basted biotechnology company. Founded in 1984, the company's innovative product pipeline includes Immunology, Molecular Biology, and RNA and DNA isolation products.

Calbiotech Inc

Company Type: Parent

Calbiotech specialty is in custom design of immunoassay products for human and animal applications.

Innominata dba GenBio

Company Type: Parent

Formed in 1994, GenBio is an experienced, fully integrated medical diagnostic company focused on infectious disease and autoimmune disease diagnostics. GenBio develops, manufactures and markets extensive lines of infectious disease and autoimmunity serology products under U.S. FDA and ISO 13485 standards.

International Immuno-Diagnostics

Company Type: Parent

Strategic focus in lab research offering an extensive range of products. Emerging as a fully integrated enterprise having fused research and development with global marketing and distribution.

SCIMEDX Corp

Company Type: Parent

SCIMEDX Corporation is a highly flexible company, with over 30 years in the medical diagnostics industry, specializing in IFA, ELISA, and automated laboratory platforms, with a focus on autoimmune diseases. The strength of the organization is the collective diversified experiences of the personnel in many areas of diagnostics and biochemistry.

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-9 of 9 Match(es).

 

Medical Product Guide Ophthalmology Management Product Guide